abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Financing Cash Flow
-$48.23M
TTM · Period ending: · USD
HQL Financing Cash Flow
Latest reported-$48.23Mperiod ending
Latest reported-$48.23Mperiod ending
HQL TTM Cash from Financing (-$6.30M → -$48.23M)
TTM financing cash flow
High-resolution chart · PNG
HQL financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -48,228,288 | |
| -31,633,006 | |
| -8,414,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,067 | |
| 0 | |
| 58,614 | |
| 52,530 | |
| 37,426 | |
| 45,294 | |
| -4,124,584 | |
| -21,112,218 | |
| -80,257,182 | |
| -139,404,982 | |
| -138,943,718 | |
| -125,600,000 | |
| -70,250,000 | |
| -14,900,000 | |
| -17,150,000 | |
| -19,400,000 | |
| -20,900,000 | |
| -22,400,000 | |
| 13,650,000 | |
| 49,700,000 | |
| 51,350,000 | |
| 53,000,000 | |
| 20,000,000 | |
| -13,000,000 | |
| -12,300,000 | |
| -11,600,000 | |
| -12,350,000 | |
| -13,100,000 | |
| -14,200,000 | |
| -15,300,000 | |
| -13,280,000 | |
| -9,700,000 | |
| -8,800,000 | |
| -7,900,000 | |
| -6,320,000 | |
| -6,300,000 |